Literature DB >> 18639369

1,5-Benzothiazepine, a versatile pharmacophore: a review.

Jitender B Bariwal1, Kuldip D Upadhyay, Atul T Manvar, Jalpa C Trivedi, Jyoti S Singh, Kishor S Jain, Anamik K Shah.   

Abstract

1,5-Benzothiazepine and 1,5-benzodiazipine are the two main seven-membered heterocyclic ring systems reported for their cardiac and psychotherapeutic activities. Successful introduction of diltiazem and clentiazem for angina pectoris, hypertension, arrhythmias and other related cardiac disorders proved potential of 1,5-benzothiazepine moiety. Subsequently 1,5-benzodiazepines were highlighted as important biologically active scaffolds. Also, discovery of thiazesim and quetiapine fumarate as psychotropic agents attracted much attention worldwide. The current review article focuses on pharmacological profile associated with 1,5-benzodiazepines. This article mainly covers structural modifications done for various targets along with the brief description of the targets.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18639369     DOI: 10.1016/j.ejmech.2008.05.035

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

1.  Synthesis of 1,5-benzothiazepine derivatives bearing 2-phenoxy-quinoline moiety via 1,3-diplolar cycloaddition reaction.

Authors:  Zhi-Qiang Dong; Fang-Ming Liu; Feng Xu; Zai-Liang Yuan
Journal:  Mol Divers       Date:  2011-08-12       Impact factor: 2.943

2.  1,5-Benzothiazepine Derivatives: Green Synthesis, In Silico and In Vitro Evaluation as Anticancer Agents.

Authors:  Michelyne Haroun; Santosh S Chobe; Rajasekhar Reddy Alavala; Savita M Mathure; Risy Namratha Jamullamudi; Charushila K Nerkar; Vijay Kumar Gugulothu; Christophe Tratrat; Mohammed Monirul Islam; Katharigatta N Venugopala; Mohammed Habeebuddin; Mallikarjun Telsang; Nagaraja Sreeharsha; Md Khalid Anwer
Journal:  Molecules       Date:  2022-06-10       Impact factor: 4.927

3.  Ferrocene anchored activated carbon as a versatile catalyst for the synthesis of 1,5-benzodiazepines via one-pot environmentally benign conditions.

Authors:  Suman Kusuma; Komal N Patil; Puneethkumar M Srinivasappa; Nitin Chaudhari; Ajay Soni; Walid Nabgan; Arvind H Jadhav
Journal:  RSC Adv       Date:  2022-05-17       Impact factor: 4.036

4.  In silico modeling of the specific inhibitory potential of thiophene-2,3-dihydro-1,5-benzothiazepine against BChE in the formation of beta-amyloid plaques associated with Alzheimer's disease.

Authors:  Zaheer Ul-Haq; Waqasuddin Khan; Saima Kalsoom; Farzana L Ansari
Journal:  Theor Biol Med Model       Date:  2010-06-16       Impact factor: 2.432

5.  Synthesis of Novel 2,3-Dihydro-1,5-Benzothiazepines as α-Glucosidase Inhibitors: In Vitro, In Vivo, Kinetic, SAR, Molecular Docking, and QSAR Studies.

Authors:  Rabia Mehmood; Ehsan Ullah Mughal; Eslam B Elkaeed; Rami J Obaid; Yasir Nazir; Hanan A Al-Ghulikah; Nafeesa Naeem; Munirah M Al-Rooqi; Saleh A Ahmed; Syed Wadood Ali Shah; Amina Sadiq
Journal:  ACS Omega       Date:  2022-08-17

6.  Discovery, optimization, and characterization of novel D2 dopamine receptor selective antagonists.

Authors:  Jingbo Xiao; R Benjamin Free; Elena Barnaeva; Jennie L Conroy; Trevor Doyle; Brittney Miller; Marthe Bryant-Genevier; Mercedes K Taylor; Xin Hu; Andrés E Dulcey; Noel Southall; Marc Ferrer; Steve Titus; Wei Zheng; David R Sibley; Juan J Marugan
Journal:  J Med Chem       Date:  2014-04-10       Impact factor: 7.446

7.  Molecular docking based screening of G6PS with 1, 5 Benzothiazepine derivates for a potential inhibitor.

Authors:  Maruthi Malya Prasada Rao Chennu; Rahaman Shaik Abdul; Rajendra Prasad Yejella
Journal:  Bioinformation       Date:  2015-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.